A perspective on the current treatment strategies for locally advanced rectal cancer

Antonio Avallone; Luigi Aloj; Giuseppe Aprile; Gerardo Rosati; Alfredo Budillon

doi:10.1016/j.biocel.2015.06.002

A perspective on the current treatment strategies for locally advanced rectal cancer

Antonio Avallone, Luigi Aloj, Giuseppe Aprile, Gerardo Rosati, Alfredo Budillon

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Abstract

The introduction of total mesorectal excision (TME) and preoperative multimodality treatment have substantially improved the management of rectal cancer reducing local recurrence and increasing sphincter-saving surgery; distant metastases however remain a clinical challenge. Besides, although surgery remains the mainstay for cure of rectal cancer with the multimodality approach (chemotherapy, radiotherapy and surgery) being the standard of care for the majority of rectal cancer patients, there is a need of individualized risk-adapted treatment schemes based on clinico-pathological features because of treatment-induced morbidity and quality of life deterioration. This short viewpoint describes the emerging strategies addressing all these issues.

Original language	English
Pages (from-to)	192-196
Number of pages	5
Journal	International Journal of Biochemistry and Cell Biology
Volume	65
DOIs	https://doi.org/10.1016/j.biocel.2015.06.002
Publication status	Published - Jun 19 2015

Keywords

Adjuvant treatment
Consolidation chemotherapy
Induction chemotherapy
Organ-preservation
Preoperative chemo-radiotherapy (CRT)
Rectal cancer
Short-course radiotherapy (SCRT)

ASJC Scopus subject areas

Biochemistry
Cell Biology

Access to Document

10.1016/j.biocel.2015.06.002

Cite this

@article{207fcd750b9b4163972731710947dc4c,

title = "A perspective on the current treatment strategies for locally advanced rectal cancer",

abstract = "The introduction of total mesorectal excision (TME) and preoperative multimodality treatment have substantially improved the management of rectal cancer reducing local recurrence and increasing sphincter-saving surgery; distant metastases however remain a clinical challenge. Besides, although surgery remains the mainstay for cure of rectal cancer with the multimodality approach (chemotherapy, radiotherapy and surgery) being the standard of care for the majority of rectal cancer patients, there is a need of individualized risk-adapted treatment schemes based on clinico-pathological features because of treatment-induced morbidity and quality of life deterioration. This short viewpoint describes the emerging strategies addressing all these issues.",

keywords = "Adjuvant treatment, Consolidation chemotherapy, Induction chemotherapy, Organ-preservation, Preoperative chemo-radiotherapy (CRT), Rectal cancer, Short-course radiotherapy (SCRT)",

author = "Antonio Avallone and Luigi Aloj and Giuseppe Aprile and Gerardo Rosati and Alfredo Budillon",

year = "2015",

month = jun,

day = "19",

doi = "10.1016/j.biocel.2015.06.002",

language = "English",

volume = "65",

pages = "192--196",

journal = "International Journal of Biochemistry and Cell Biology",

issn = "1357-2725",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - A perspective on the current treatment strategies for locally advanced rectal cancer

AU - Avallone, Antonio

AU - Aloj, Luigi

AU - Aprile, Giuseppe

AU - Rosati, Gerardo

AU - Budillon, Alfredo

PY - 2015/6/19

Y1 - 2015/6/19

N2 - The introduction of total mesorectal excision (TME) and preoperative multimodality treatment have substantially improved the management of rectal cancer reducing local recurrence and increasing sphincter-saving surgery; distant metastases however remain a clinical challenge. Besides, although surgery remains the mainstay for cure of rectal cancer with the multimodality approach (chemotherapy, radiotherapy and surgery) being the standard of care for the majority of rectal cancer patients, there is a need of individualized risk-adapted treatment schemes based on clinico-pathological features because of treatment-induced morbidity and quality of life deterioration. This short viewpoint describes the emerging strategies addressing all these issues.

AB - The introduction of total mesorectal excision (TME) and preoperative multimodality treatment have substantially improved the management of rectal cancer reducing local recurrence and increasing sphincter-saving surgery; distant metastases however remain a clinical challenge. Besides, although surgery remains the mainstay for cure of rectal cancer with the multimodality approach (chemotherapy, radiotherapy and surgery) being the standard of care for the majority of rectal cancer patients, there is a need of individualized risk-adapted treatment schemes based on clinico-pathological features because of treatment-induced morbidity and quality of life deterioration. This short viewpoint describes the emerging strategies addressing all these issues.

KW - Adjuvant treatment

KW - Consolidation chemotherapy

KW - Induction chemotherapy

KW - Organ-preservation

KW - Preoperative chemo-radiotherapy (CRT)

KW - Rectal cancer

KW - Short-course radiotherapy (SCRT)

UR - http://www.scopus.com/inward/record.url?scp=84935826888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935826888&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2015.06.002

DO - 10.1016/j.biocel.2015.06.002

M3 - Article

C2 - 26055517

AN - SCOPUS:84935826888

VL - 65

SP - 192

EP - 196

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

ER -

A perspective on the current treatment strategies for locally advanced rectal cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this